177 related articles for article (PubMed ID: 38707238)
1. Novel biomarkers and strategies for HCC diagnosis and care.
Wang AE; Leven EA; Grinspan LT; Villanueva A
Clin Liver Dis (Hoboken); 2024; 23(1):e0152. PubMed ID: 38707238
[No Abstract] [Full Text] [Related]
2. Biomarkers for the early diagnosis of hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
[TBL] [Abstract][Full Text] [Related]
3. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
Song P; Tang Q; Feng X; Tang W
Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
[TBL] [Abstract][Full Text] [Related]
5. Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers.
Ayoub WS; Steggerda J; Yang JD; Kuo A; Sundaram V; Lu SC
Ther Adv Med Oncol; 2019; 11():1758835919869120. PubMed ID: 31523283
[TBL] [Abstract][Full Text] [Related]
6. Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis.
Rui T; Zhang X; Guo J; Xiang A; Tang N; Liu J; Mao Z
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612201
[TBL] [Abstract][Full Text] [Related]
7. The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipation.
Mir IH; Jyothi KC; Thirunavukkarasu C
J Cell Biochem; 2022 Oct; 123(10):1607-1623. PubMed ID: 34897788
[TBL] [Abstract][Full Text] [Related]
8. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma.
Wang T; Zhang KH
Front Oncol; 2020; 10():1316. PubMed ID: 32923383
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Hu X; Bao M; Huang J; Zhou L; Zheng S
Front Oncol; 2020; 10():541479. PubMed ID: 33102213
[No Abstract] [Full Text] [Related]
12. Discovering Novel Prognostic Biomarkers of Hepatocellular Carcinoma using eXplainable Artificial Intelligence.
Gutierrez-Chakraborty E; Chakraborty D; Das D; Bai Y
bioRxiv; 2023 Nov; ():. PubMed ID: 38076789
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma.
Kim KH; Kim JY; Yoo JS
Expert Rev Proteomics; 2019 Jul; 16(7):553-568. PubMed ID: 31145639
[No Abstract] [Full Text] [Related]
14. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
Zhao J; Wang Y; Su H; Su L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis.
Yuan D; Chen Y; Li X; Li J; Zhao Y; Shen J; Du F; Kaboli PJ; Li M; Wu X; Ji H; Cho CH; Wen Q; Li W; Xiao Z; Chen B
Int J Biol Sci; 2021; 17(1):220-235. PubMed ID: 33390845
[TBL] [Abstract][Full Text] [Related]
16. Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Zeng Y; Hu S; Luo Y; He K
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765333
[TBL] [Abstract][Full Text] [Related]
17. Novel Three-Dimensional Hierarchical Porous Carbon Probe for the Discovery of N-Glycan Biomarkers and Early Hepatocellular Carcinoma Detection.
Wang J; Liu J; Li M; Wang Y; Man Q; Zhang H; Huang LH; Zhang X
Anal Chem; 2023 Jul; 95(27):10231-10240. PubMed ID: 37322584
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on a combined test of multi serum biomarkers in China: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage.
Zhang K; Song P; Gao J; Li G; Zhao X; Zhang S
Drug Discov Ther; 2014 Jun; 8(3):102-9. PubMed ID: 25031041
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for hepatocellular carcinoma based on body fluids and feces.
Guan MC; Ouyang W; Wang MD; Liang L; Li N; Fu TT; Shen F; Lau WY; Xu QR; Huang DS; Zhu H; Yang T
World J Gastrointest Oncol; 2021 May; 13(5):351-365. PubMed ID: 34040698
[TBL] [Abstract][Full Text] [Related]
20. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma.
Song T; Li L; Wu S; Liu Y; Guo C; Wang W; Dai L; Zhang T; Wu H; Su B
Front Oncol; 2021; 11():583714. PubMed ID: 33777736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
